Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment)

• 主要な著者: Nakamura T (著者), Kubota T (著者), Iwakaji A (著者), Imada M (著者), Kapás M (著者), Morio Y (著者)
• フォーマット: 図書
• 出版事項: Dove Medical Press, 2016-01-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Tadakatsu Nakamura,1 Tomoko Kubota,1 Atsushi Iwakaji,1 Masayoshi Imada,1 Margit Kapás,2 Yasunori Morio1 1Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan; 2Developmental Drug Metabolism and Pharmacokinetics, Gedeon Richter Plc, Budapest, Hungary Purpose: Cari...